V006-1725 Screening compound: 1-(2,3,4,5,6-pentafluorobenzoyl)-4-[7-(pyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]piperazine

V006-1725 Screening compound: 1-(2,3,4,5,6-pentafluorobenzoyl)-4-[7-(pyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]piperazine
V006-1725 Screening compound: 1-(2,3,4,5,6-pentafluorobenzoyl)-4-[7-(pyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V006-1725
1-(2,3,4,5,6-pentafluorobenzoyl)-4-[7-(pyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V006-1725

Molecular Formula

C21H14F5N7O (C21 H14 F5 N7 O)

Compound Name

1-(2,3,4,5,6-pentafluorobenzoyl)-4-[7-(pyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]piperazine

IUPAC name

1-(23456-pentafluorobenzoyl)-4-[7-(pyridin-3-yl)-[124]triazolo[15-a]pyrimidin-2-yl]piperazine

SMILES

O=C(c(c(F)c(c(F)c1F)F)c1F)N(CC1)CCN1c1nn2c(-c3cnccc3)ccnc2n1

InChI

InChI=1S/C21H14F5N7O/c22-14-13(15(23)17(25)18(26)16(14)24)19(34)31-6-8-32(9-7-31)21-29-20-28-5-3-12(33(20)30-21)11-2-1-4-27-10-11/h1-5,10H,6-9H2

InChI Key

VPJLYKPBUAXGEV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19955188

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

475.38

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.732

Distribution Coefficient, logD

2.731

Water Solubility, LogSw

-2.51

Polar Surface Area

58.566

Acid Dissociation Constant (pKa)

20.52

Base Dissociation Constant (pKb)

4.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

V006-1725 in Drug Discovery

Included in Screening Libraries

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V006-1725 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V006-1725?
Check Price and Availability of V006-1725, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V006-1725 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V006-1725
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V006-1725
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V006-1725 available by request